'Et tu, inhibitor?': the potential for HIV inhibitors to prime P-gp-mediated chemoresistance in cancer

Future Sci OA. 2017 Nov 23;4(2):FSO269. doi: 10.4155/fsoa-2017-0134. eCollection 2018 Feb.

Authors

Austin Y Shull^{1

1}, Christopher L Farrell^{2

2}

Affiliations

¹ Department of Biology, Presbyterian College, Clinton, SC 29325, USA.
² Department of Pharmaceutical & Administrative Sciences, Presbyterian College School of Pharmacy, Clinton, SC 29325, USA.

No abstract available

Keywords: HIV inhibitors; P-gp; cancer; chemoresistance; drug resistance; pharmacogenomics.

Publication types

Editorial